Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice
- 1 April 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 329 (4) , 1217-1224
- https://doi.org/10.1016/j.bbrc.2005.01.166
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hepatocyte Growth Factor Facilitates Colonic Mucosal Repair in Experimental Ulcerative Colitis in RatsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Gene transfer approaches for the treatment of inflammatory bowel diseaseGene Therapy, 2003
- The intestinal epithelial stem cellBioEssays, 2002
- Crohn's diseaseThe Lancet, 2002
- Adenovirus-Mediated Hepatocyte Growth Factor Gene Transfer Prevents Lethal Liver Failure in RatsBiochemical and Biophysical Research Communications, 2000
- Hepatocyte growth factor accelerates restitution of intestinal epithelial cellsThe Esophagus, 1998
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Gene expression of keratinocyte and hepatocyte growth factors during the healing of rat gastric mucosal lesionsGastroenterology, 1995
- Hepatocyte Growth Factor/Scatter Factor Modulates Intestinal Epithelial Cell Proliferation and MigrationBiochemical and Biophysical Research Communications, 1994
- Colon Cancer, Dysplasia, and Surveillance in Patients with Ulcerative ColitisNew England Journal of Medicine, 1987